Pure Biologics S.A. (WSE: PUR)

Pure Biologics Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.29	3.61	2.26	6.18	8.96	13.92
Short-Term Investments	-	-	4.92	26.75	-	-
Cash & Short-Term Investments	5.29	3.61	7.18	32.93	8.96	13.92
Cash Growth	-71.23%	-49.76%	-78.20%	267.68%	-35.67%	7004.91%
Accounts Receivable	0.08	0.02	0.15	0.05	0.02	0.19
Other Receivables	9.82	14.73	15.07	9.24	1.34	0.83
Receivables	9.9	14.75	15.22	9.29	1.35	1.01
Inventory	-	-	-	-	-	0.09
Prepaid Expenses	-	0.03	0.02	0.03	0.02	-
Other Current Assets	3.51	3.22	1.76	0.77	2.71	0.09
Total Current Assets	18.69	21.6	24.17	43.02	13.04	15.11
Property, Plant & Equipment	0.74	3.7	8.42	3.45	4.88	5.35
Long-Term Investments	-	-	0.02	0.02	-	-
Other Intangible Assets	0.22	0.26	0.29	0.33	0.37	0.28
Long-Term Deferred Charges	-	-	0.11	0.39	0.65	0.34
Other Long-Term Assets	-	-2.82	-	-	-	-
Total Assets	19.65	22.74	33.01	47.19	18.94	21.09
Accounts Payable	2.77	1.03	7.24	0.67	2.76	0.9
Accrued Expenses	1.2	0.92	1.64	0.08	1.49	1.3
Current Portion of Leases	0.11	0.09	1.1	1.11	1.38	1.96
Current Unearned Revenue	4.81	4.81	2.79	3.68	12.23	7.99
Other Current Liabilities	0.69	1.15	0.08	0	0.15	0.17
Total Current Liabilities	9.58	7.99	12.83	5.55	18	12.33
Long-Term Debt	13.02	12.72	-	-	-	-
Long-Term Leases	0.13	0.13	1.77	2	3.63	3.42
Long-Term Unearned Revenue	-	-	0.07	0.11	0.15	0.19
Other Long-Term Liabilities	0	-	-	0	0	-
Total Liabilities	22.73	20.85	14.71	7.7	21.83	15.97
Common Stock	0.33	0.33	0.23	0.23	0.17	0.17
Additional Paid-In Capital	90.57	90.57	75.31	70.89	16.82	13.07
Retained Earnings	-97.9	-92.93	-57.24	-31.63	-19.87	-8.11
Comprensive Income & Other	3.92	3.92	0	-	0	-
Shareholders' Equity	-3.08	1.89	18.3	39.49	-2.89	5.12
Total Liabilities & Equity	19.65	22.74	33.01	47.19	18.94	21.09
Total Debt	13.26	12.94	2.86	3.11	5.01	5.37
Net Cash (Debt)	-7.97	-9.33	4.32	29.82	3.95	8.55
Net Cash Growth	-	-	-85.52%	654.64%	-53.78%	8272.18%
Net Cash Per Share	-2.45	-2.93	1.92	13.42	2.39	5.61
Filing Date Shares Outstanding	3.33	3.33	2.25	2.25	1.65	1.65
Total Common Shares Outstanding	3.33	3.33	2.25	2.25	2.25	1.65
Working Capital	9.11	13.61	11.34	37.47	-4.96	2.79
Book Value Per Share	-0.92	0.57	8.12	17.52	-1.28	3.09
Tangible Book Value	-3.3	1.64	18.01	39.16	-3.26	4.84
Tangible Book Value Per Share	-0.99	0.49	7.99	17.37	-1.45	2.93
Land	-	-	0.1	0.87	-	-
Machinery	-	11.25	11.95	10.95	9.88	7.83

Source: S&P Capital IQ. Standard template. Financial Sources.